Bruker Corporation (BRKR) SEC Filings & Earnings Calls

Goodwill Impairment Risk

“During the three and six months ended June 30, 2026, the Company recorded a goodwill impairment charge of $134.9 million”

Restructuring Execution Risk

“The Corporate-wide Restructuring Plan was completed during the second quarter of 2026, and no further costs are expected to be incurred in connection therewith.” · word for word

China Revenue Decline

“China $ 104.9 $ 114.7”

Negative Operating Cash Flow

“Net cash used in operating activities (6.2) (62.5)” · word for word

Minority Investment Impairment

“the Company recorded impairment charges of $4.1 million and $4.7 million during the three and six months ended June 30, 2026” · word for word

Goodwill impairment of $134.9M indicates potential overpayment or underperformance in prior acquisitions.

“Non-cash goodwill impairment charges of $134.9 million in Q2-26.”

US academic demand remains soft, a key end market for BSI.

“US academic demand remained soft in Q2.” · word for word

Currency headwind of ~$0.10 on FY26 non-GAAP EPS guidance.

“Currency headwind of approximately $0.10, or 5%.” · word for word

Tariff and Trade Policy Uncertainty

“These tariff measures and the related uncertainty in global trade markets have contributed to lower‑than‑anticipated bookings, revenues, and profitability, and may continue to adversely affect our business for the foreseeable future.” · word for word

Academic and Government Market Weakness

“The non-GAAP CER revenue decline during the three months ended March 31, 2026, was driven primarily by weaker demand in the academic and government research and industrial markets for our analytical instruments” · word for word

Foreign Exchange Volatility

“The decrease in total gross profit and gross profit margin during the three months ended March 31, 2026, was driven primarily by foreign exchange headwinds from a declining U.S. Dollar” · word for word

Restructuring Execution Risk

“we announced a cost savings initiative aimed at reducing annualized costs by approximately $100 million to $120 million by the end of 2026.” · word for word

Organic revenue declined 4.4% yoy in Q1, impacted by US academic demand, tariff and currency headwinds.

“revenues decreased organically by 4.4% yoy” · word for word

GAAP operating income significantly lower than non-GAAP due to adjustments.

“Q1-26 GAAP operating income was $10.2 million, compared to non-GAAP operating income of $84.2 million” · word for word

Loss of key BioSpin leadership may impact segment performance and strategic execution.

“President of Bruker BioSpin departing; no successor named.”

Weak Financial Performance and Pay Cuts

“Non-GAAP diluted EPS decreased by 24.1% to $1.83 from $2.41 in fiscal year 2024.” · word for word

Key Person Risk - CEO Concentration

“Frank H. Laukien (2) 40,510,066 26.6%” · word for word

Tariff cost pressure

“During the year ended December 31, 2025, our results of operations were adversely impacted by an increase in cost of goods sold as a result of increased tariffs.” · word for word

US academic funding reduction

“The current reduction in the level of funding and delay in such research funding, has had a material adverse effect on our U.S. academic and governmental customers, and our business, results of operations and financial condition.” · word for word

China stimulus delay

“In 2025, the release of such Chinese government stimulus spending was delayed, which has negatively affected our sales growth into China and consequently has had an adverse effect on our business, results of operations, and financial condition in 2025.” · word for word

Goodwill impairment

“During the year ended December 31, 2025, the Company recorded impairment losses for certain goodwill and intangible assets as disclosed in Note 6, Goodwill and Intangible Assets to our consolidated financial statements included in” · word for word

No material risks identified; routine director changes and dividend declaration.

“No disagreements or operational issues cited.”

Academic funding headwinds and tariffs continue to pressure organic growth.

“headwinds from academic funding, tariffs and currencies” · word for word

FY25 GAAP results impacted by significant impairment and restructuring charges.

“non-cash impairment charges to goodwill and intangible assets totaling $127.2 million and restructuring charges of $77.4 million” · word for word

FX headwind of ~8% expected to impact FY26 EPS growth.

“including an ~8% FX headwind” · word for word

Preliminary results subject to audit adjustments; revenue guidance flat to low-single digits suggests limited top-line momentum.

“Because the Company’s financial statements for the fourth quarter and fiscal year ended December 31, 2025 have not yet been finalized or audited ... the preliminary statements ... are subject to change” · word for word

No material risks; routine board appointment.

Goodwill Impairment Risk

“During the three and nine months ended September 30, 2025, the Company recorded a goodwill impairment charge of $96.5 million on the unaudited condensed consolidated statements of operations, which represented the amount by which the carrying value of the Bruker Spatial Biology reporting unit and Automation reporting unit exceeded the respective reporting un” · word for word

Tariff and Trade Policy Risk

“The slight decrease in Non-GAAP gross profit margin ... was driven by decline of revenue primarily as result of slower demand in academic and government research markets, combined with an increase in cost of goods sold due to higher U.S. tariffs and foreign exchange headwinds from a declining U.S. dollar.” · word for word

Academic/Government Funding Dependency

“Revenue decreases ... were primarily attributable to the BSI BioSpin and BSI Nano Segments with the decline primarily driven by weaker demand in the academic and government research and biopharma markets for life science instruments.”

Significant goodwill and intangible asset impairment of $119.4M indicates overpayment or deterioration in acquired businesses.

“Non-cash impairment charges related to goodwill and intangible assets totaling $119.4M.” · word for word

Restructuring charges of $34.5M indicate cost-cutting measures, which may impact operations.

“Restructuring charges of $34.5M.”

Organic revenue decline of 4-5% expected for full year, indicating weak end-market demand.

“FY2025 organic revenue decline of 4% to 5%.”